Markets:

Overview

News

Currencies

International

Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

47.94 +1.77 (+3.82%)

Streaming Delayed Price Updated: 2:23 PM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Napco Security Technologies Posts Downbeat Results, Joins Centrus Energy, Constellation Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 04, 2024

Via Benzinga

10 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 04, 2024

Via Benzinga

AI Stocks Meta, Oracle Lead Five Names Near Buy Points ↗

November 02, 2024

Two of the 5 top stocks to watch this week tap the artificial intelligence market.

Via Investor's Business Daily

Topics Artificial Intelligence

As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report ↗

November 01, 2024

Amid the election, and a Fed rate vote, earnings season roars ahead.

Via Investor's Business Daily

Topics Economy Stocks

The Analyst Verdict: TG Therapeutics In The Eyes Of 5 Experts ↗

October 29, 2024

Via Benzinga

Delving into NASDAQ:TGTX's Growth Prospects. ↗

October 21, 2024

Why TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock.

Via Chartmill

Why NASDAQ:TGTX qualifies as a high growth stock. ↗

October 15, 2024

Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing?

Via Chartmill

Investors seeking growth at a reasonable cost should explore NASDAQ:TGTX. ↗

October 30, 2024

TG THERAPEUTICS INC (NASDAQ:TGTX) stands out as a growth opportunity that won't break the bank.

Via Chartmill

NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

October 15, 2024

TG THERAPEUTICS INC (NASDAQ:TGTX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

Via Chartmill

For those who appreciate growth without the sticker shock, NASDAQ:TGTX is worth considering. ↗

October 09, 2024

NASDAQ:TGTX is showing decent growth, but is still valued reasonably.

Via Chartmill

Unlocking the Growth Potential of NASDAQ:TGTX. ↗

September 30, 2024

TG THERAPEUTICS INC (NASDAQ:TGTX) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 23, 2024

Via Benzinga

Stock Market Hits Record Highs On Big Fed Rate Cut; Apple, Intel, FedEx In Focus: Weekly Review ↗

September 20, 2024

TheApple iPhone 16 went on sale amid mixed signals about demand.

Via Investor's Business Daily

Topics Economy

Evaluating TG Therapeutics: Insights From 4 Financial Analysts ↗

September 18, 2024

Via Benzinga

What's Going On With TG Therapeutics Stock Wednesday? ↗

September 18, 2024

TG Therapeutics announced it updated its data presentations to include details from the ULTIMATE I & II Phase 3 trials.

Via Benzinga

IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug ↗

September 18, 2024

The company unveiled five-year test results for its multiple sclerosis drug, Briumvi.

Via Investor's Business Daily

Despite its growth, NASDAQ:TGTX remains within the realm of affordability. ↗

September 18, 2024

While growth is established for TG THERAPEUTICS INC (NASDAQ:TGTX), the stock's valuation remains reasonable.

Via Chartmill

NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

September 16, 2024

TG THERAPEUTICS INC (NASDAQ:TGTX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

Via Chartmill

What's Going On With ADMA Biologics Stock Monday? ↗

September 09, 2024

ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600.

Via Benzinga

Topics Stocks

Why NASDAQ:TGTX is Poised for High Growth. ↗

September 09, 2024

Exploring TG THERAPEUTICS INC (NASDAQ:TGTX)'s growth characteristics.

Via Chartmill

In the world of growth stocks, NASDAQ:TGTX shines as a value proposition. ↗

August 28, 2024

NASDAQ:TGTX, a growth stock which is not overvalued.

Via Chartmill

Decoding TG Therapeutics's Options Activity: What's the Big Picture? ↗

August 19, 2024

Via Benzinga

Why the growth investor may take a look at NASDAQ:TGTX. ↗

August 19, 2024

Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for growth investing?

Via Chartmill

A Closer Look at TG Therapeutics's Options Market Dynamics ↗

August 16, 2024

Via Benzinga

NASDAQ:TGTX: a strong growth stock preparing for the next leg up?. ↗

August 13, 2024

TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock and is consolidating.

Via Chartmill

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 19, 2024

Via Benzinga

IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter ↗

August 19, 2024

The company reported a surprise profit in the second quarter, vs. expectations for losses.

Via Investor's Business Daily

ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday ↗

August 19, 2024

Via Benzinga

NASDAQ:TGTX is showing decent growth, but is still valued reasonably. ↗

August 07, 2024

NASDAQ:TGTX stands out as a growth opportunity that won't break the bank.

Via Chartmill

Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review ↗

August 09, 2024

After Monday's panicked global sell-off, markets have calmed down.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.